Uva Ursi Safety: Hydroquinone Risk and Who Should Avoid It

Most readers arrive at a safety page after deciding to take something. If you are reading this with an infection already underway, we are going to reverse the usual order, because the most dangerous thing about uva ursi is not the herb — it is the delay. Go straight to Red Flags first. That list is the part of this page most likely to change what happens to you.

Then come back for the rest, which is about hydroquinone. Uva ursi's proposed active moiety is hydroquinone, a reactive phenol with a substantial toxicology file. That is not a reason for panic — a formal assessment found that short-course, recommended-dose use delivers only a small amount of free hydroquinone — but it is the reason the herb comes with a hard duration ceiling instead of an open-ended “take as needed.” And it is why the safety discussion for bearberry is qualitatively different from, say, chamomile.

One more piece of context that belongs at the top: the randomized placebo-controlled trial of uva ursi in uncomplicated urinary infection was negative. When a remedy has no demonstrated benefit, even a modest risk is a poor trade. See What the Trials Show.

Red Flags: Stop Self-Treating and Get Care
Hepatotoxicity: The Liver Concern
The Genotoxicity Question, Honestly Stated
Green-Brown Urine: Expected and Harmless
Nausea, Stomach Irritation and the Tannins
Kidney Disease: Why This Is an Absolute Avoid
Pregnancy, Breastfeeding and Children
The Full Avoid List
Interactions and Combinations to Be Careful With
Signs You Have Taken Too Much or Used It Too Long
What Can Be Checked, and When
Evidence Tiers at a Glance
The Bottom Line
Key Research Papers
Connections

Red Flags: Stop Self-Treating and Get Care

This is the most important section on the page. If any of the following applies, the right action is medical assessment — today, not after a few more days of tea. The trial evidence is explicit that replacing treatment with uva ursi produced more kidney infections, so “wait and see” is a choice with a documented cost.

Fever, or chills and shivering. A simple bladder infection does not usually cause fever. Fever suggests the infection has reached the kidney.
Flank or back pain — ache or tenderness in the side or the small of the back, often worse on one side. Classic upper urinary tract sign.
Nausea or vomiting. Both point away from a simple bladder infection, and vomiting also means you cannot reliably keep fluids or medicine down.
Blood in the urine you can see. Infection is a common cause, but not the only one, and visible blood warrants assessment on its own merits.
Pregnancy. Urinary infection in pregnancy is treated promptly because untreated infection carries risks to the pregnancy. Uva ursi is contraindicated in pregnancy regardless.
Male sex. Urinary infection in men is not classed as uncomplicated; it needs assessment for prostate and structural involvement.
Children. A child with urinary symptoms needs to be seen, and uva ursi is not recommended for children at all.
Recurrent infection — multiple episodes within a year. This needs a plan and possibly investigation, and repeated self-treatment breaches the herb's yearly limit anyway.
No clear improvement within 48 hours, or any worsening at any point.
Diabetes, immune suppression, kidney disease, a urinary catheter, a kidney stone, a known structural abnormality, or a recent urological procedure. All take the episode out of the “simple” category.
Confusion, new drowsiness, or unsteadiness in an older adult. Infection in older people often presents this way rather than with burning.
Feeling very unwell, a racing heart, breathlessness, or light-headedness on standing. Get urgent care — these can be signs of a bloodstream infection.

Background on the condition and the escalation: Urinary Tract Infections and Pyelonephritis. A dipstick and urine culture take the guesswork out; see Urinalysis.

Hepatotoxicity: The Liver Concern

Evidence tier: established toxicology of the constituent; no established pattern of liver injury from short-course bearberry use.

Two things are true at once here, and it is worth holding both.

First, hydroquinone is hepatotoxic at sufficient exposure. It is metabolised in the liver, and its toxicology — reviewed in The toxicology of hydroquinone — relevance to occupational and environmental exposure, Critical Reviews in Toxicology (1999) — includes liver effects in animal studies at meaningful doses. Because uva ursi's entire proposed action depends on delivering hydroquinone, this is not an incidental contaminant concern. It is a property of the active. PubMed search: hydroquinone toxicology

Second, there is no established pattern of liver injury from bearberry leaf taken at monograph doses for a week. The formal assessment specific to bearberry preparations — Risk assessment of free hydroquinone derived from Arctostaphylos uva-ursi folium herbal preparations, International Journal of Toxicology (2013) — concluded that the free hydroquinone actually delivered at recommended doses is small and within accepted safety margins. PubMed search: bearberry hydroquinone risk assessment

The reconciliation is straightforward and is the whole reason the duration cap exists: the reassuring conclusion is conditional on the usage pattern. It applies to a week at recommended doses. It does not extend to daily use for a month, to double doses, or to stacked products. If you leave those conditions, you have left the assessment that made the herb look acceptable, and nobody has characterised where you now are.

Signs of liver trouble worth knowing regardless of cause — and reasons to stop immediately and be seen:

Yellowing of the skin or the whites of the eyes.
Dark urine that is not the expected green-brown, especially with pale stools.
Persistent nausea, loss of appetite, or unusual fatigue.
Pain or discomfort under the right ribs.
Generalised itching without a rash.

Anyone with existing liver disease should not use uva ursi outside medical supervision. See Liver Disease. Liver enzymes are a routine blood test if there is any doubt; see Lab Tests.

The Genotoxicity Question, Honestly Stated

Evidence tier: established laboratory genotoxicity of hydroquinone; unresolved relevance at bearberry exposures.

This is the part usually either ignored entirely or inflated into scaremongering. The accurate position sits between.

What is established: hydroquinone is genotoxic in a range of laboratory systems, and long-term rodent bioassays have reported tumours — kidney tubular tumours in male rats and haematological findings in females among them. Regulatory and expert bodies have grappled with what this means for humans; the dedicated evaluation Hydroquinone: an evaluation of the human risks from its carcinogenic and mutagenic properties in Critical Reviews in Toxicology (2007) is the standard reference. PubMed search: hydroquinone genotoxicity and carcinogenicity

What is not established:

That taking uva ursi for a week causes cancer. No such finding exists, and it would be wrong to imply it. Human epidemiology on bearberry use does not exist in any useful quantity, and the exposures in rodent bioassays were far higher and far longer than a short herbal course.
That the exposure is trivially safe at any duration. Equally unsupported in the other direction. Because a genotoxic mechanism has, in principle, no clean threshold, regulators handle it by minimising exposure — which in practice means short courses and few of them.

The honest summary: the genotoxicity question is unresolved, and unresolved questions about genotoxic compounds are managed by limiting exposure, not by waiting for certainty. That is precisely what the one-week, few-courses-a-year rule is. It is a precautionary structure built around an open question, and it is the reason the rule is not negotiable even though no one is claiming a week of bearberry tea will harm you.

It is also worth noticing that hydroquinone's regulatory history in cosmetics — where it is used as a skin-lightening agent and has been restricted or banned in over-the-counter products in several jurisdictions — reflects the same underlying concern by a different route. Arbutin appears in cosmetics precisely because it releases hydroquinone. That parallel does not transfer numbers, but it does confirm that regulators worldwide treat this molecule as one to limit.

Green-Brown Urine: Expected and Harmless

Evidence tier: well-recognised, expected effect.

Uva ursi commonly turns urine a greenish or greenish-brown colour. This is caused by plant pigments and phenolic metabolites being excreted, it is entirely expected, and it is harmless. It resolves within a day or so of stopping.

It is worth knowing in advance for two reasons. First, discovering it unexpectedly at night is alarming, and alarm sends people to emergency departments unnecessarily. Second — and more important — knowing what the expected discolouration looks like helps you notice the unexpected kinds:

Pink, red or cola-coloured urine is blood or possibly muscle breakdown products. That is not the herb. Get assessed.
Dark brown urine with pale stools and yellow eyes suggests a liver or bile-duct problem. Stop and get assessed.
Cloudy, foul-smelling urine with worsening symptoms is the infection progressing, not a side effect.

In short: green-brown is the herb. Anything else is not, and should be treated as a new finding rather than filed under “expected.”

Nausea, Stomach Irritation and the Tannins

Evidence tier: well-recognised, common effect.

The commonest complaint from uva ursi has nothing to do with hydroquinone. Bearberry leaf is heavily tannin-laden — often in the region of 15–20% of the dried leaf — and tannins bind proteins, which is what makes the brew so astringent and what irritates the gastric lining.

Typical effects: nausea, stomach ache, a sense of gastric burning, occasionally vomiting. They are dose-related and preparation-related. Mitigations:

Use a cold macerate rather than a hot infusion. Hot water pulls out far more tannin. The cold method is described on the dosing page. Remember it improves comfort, not hydroquinone safety.
Or use a standardised capsule, which carries a lower tannin load than a strong tea.
Take it with food.
Do not take it with an iron supplement or an iron-rich meal if you are treating iron deficiency — tannins reduce non-haem iron absorption.
Stop if vomiting starts. Vomiting during a urinary infection is itself a red flag, and it also means you cannot maintain fluids.

Anyone with gastritis, peptic ulcer disease, reflux or inflammatory bowel disease should expect a tannin-rich astringent to be poorly tolerated.

Kidney Disease: Why This Is an Absolute Avoid

Evidence tier: pharmacological reasoning, universally applied in monographs.

Uva ursi is contraindicated in kidney disease and reduced kidney function, and the reasoning is unusually clean. The herb's entire mode of action depends on the kidney filtering hydroquinone conjugates into urine. That means:

Impaired clearance changes the exposure. If the kidney is not clearing conjugates efficiently, they persist systemically for longer — the opposite of the brief-exposure pattern on which the herb's safety argument depends.
The kidney is itself a target organ in hydroquinone bioassays. Rodent studies reported renal tubular findings. Adding a hydroquinone-yielding herb to an already compromised kidney is the wrong direction of travel.
Urinary infection in someone with kidney disease is not an uncomplicated infection. It needs proper diagnosis and treatment regardless of what herbs are available.

The same logic applies to anyone taking other nephrotoxic agents — regular high-dose NSAIDs being the commonest in ordinary life. See Kidney Disease and Kidney Function Tests. If you do not know your kidney function, a basic blood test with creatinine and eGFR gives it.

A note on kidney stones: uva ursi's nineteenth-century use for “gravel” is traditional use only and is a poor idea in practice, both because it has no supporting evidence and because the alkalinising advice traditionally paired with the herb changes stone chemistry in ways that help some stone types and worsen others. See Kidney Stones.

Pregnancy, Breastfeeding and Children

Evidence tier: regulatory contraindication; avoid entirely.

Pregnancy — avoid entirely. Two separate reasons. Hydroquinone exposure to a developing fetus is not something anyone is willing to characterise, and traditional texts additionally raise concerns about effects on the uterus. Beyond the herb: urinary infection in pregnancy, including symptomless bacteriuria, is actively screened for and treated because untreated infection is associated with pyelonephritis and adverse pregnancy outcomes. Pregnancy is the single clearest case where reaching for a herb instead of care is the wrong move.
Breastfeeding — avoid entirely. Hydroquinone and its conjugates would be expected to reach the infant, and there is no basis for judging that exposure acceptable.
Children and adolescents — not recommended. European guidance does not establish use below adulthood. Children have proportionally larger exposure for a given dose, developing organ systems, and a genuine need for their urinary infections to be properly diagnosed — infection in a child can signal an underlying structural problem such as reflux, and missing it has long-term consequences for the kidneys.

The Full Avoid List

Collected in one place. For everyone in this list there is no safe dose — the answer is not to use it.

Pregnancy.
Breastfeeding.
Children and adolescents.
Kidney disease or reduced kidney function, including a single kidney or a transplant.
Liver disease, including hepatitis, cirrhosis and fatty liver disease with abnormal enzymes.
Anyone with a red flag from the list at the top of this page.
Anyone who has already used it within the last few months, such that a further course would breach the yearly limit.
Anyone who cannot commit to stopping at a week. If the intention is ongoing use, this is the wrong product.
Anyone with a known allergy to bearberry or other Ericaceae family plants.
Anyone taking a medicine whose handling by the liver or kidney is already a concern, without checking with a pharmacist or doctor first.
Anyone treating a condition that is not an infection — bladder pain syndrome and interstitial cystitis, for instance, where an astringent hydroquinone-yielding herb has no rationale. See Interstitial Cystitis.

Interactions and Combinations to Be Careful With

Formal drug-interaction studies on bearberry are sparse, so most of what follows is pharmacological caution rather than documented interaction. It is stated as such.

Anything nephrotoxic — regular high-dose NSAIDs such as ibuprofen, naproxen or diclofenac; certain antibiotics; some contrast and chemotherapy agents. The herb's metabolites are renally cleared, so do not add a renal burden on top.
Anything hepatotoxic — high-dose or frequent paracetamol/acetaminophen, heavy alcohol use, other hepatotoxic herbs. Hydroquinone is processed by the liver.
Urinary acidifiers — high-dose vitamin C, cranberry products, and methenamine-type products that require acidic urine. These pull against the traditional alkaline-urine teaching. The interaction is one of logic more than toxicity, but at minimum do not expect them to reinforce each other.
Urinary alkalinisers — sodium bicarbonate, potassium citrate. Do not add these to “potentiate” uva ursi. The sodium or potassium load matters in high blood pressure, heart failure and kidney disease, and potassium citrate specifically can be dangerous with kidney impairment or potassium-sparing medicines.
Lithium — anything with a diuretic effect can in principle alter lithium levels. Lithium has a narrow therapeutic window; do not add herbal diuretics without medical input.
Diuretics — combining a herbal diuretic with a prescribed one is an avoidable way to become dehydrated or disturb electrolytes.
Iron supplements — tannins reduce non-haem iron absorption; separate them in time.
Multiple herbal products — the practical interaction most likely to bite you. Uva ursi appears in blends alongside cranberry, dandelion, horsetail, corn silk, buchu and juniper, often without a stated arbutin content. Check every label for bearberry or arbutin before adding another product.

Tell your clinician and pharmacist what you are taking. Herbal use is not judged; it is just much easier to interpret abnormal liver tests, greenish urine or gastric symptoms when they know about it.

Signs You Have Taken Too Much or Used It Too Long

Stop and seek advice if any of these appear:

Nausea and vomiting, particularly if new or worsening.
Ringing in the ears (tinnitus). Classically described with excessive uva ursi intake.
Persistent stomach pain or gastric burning.
Yellowing of the skin or eyes, dark urine unlike the expected green-brown, pale stools, itching without rash, right-upper-abdominal pain, or unusual fatigue — possible liver involvement. Stop immediately and be assessed.
Reduced urine output, ankle swelling, or new breathlessness — possible kidney involvement.
Feeling generally unwell, feverish, or confused.
Rash, itching, facial swelling or wheeze — possible allergic reaction; seek urgent care for swelling or breathing difficulty.
You have simply lost track of the days. If you cannot say confidently that you are inside the one-week window, stop.

If a child has swallowed a quantity of uva ursi, or if an adult has taken a large amount, contact a poisons information service or emergency service rather than waiting for symptoms.

What Can Be Checked, and When

Short-course use in a healthy adult does not routinely need monitoring. Where a check is worthwhile:

Before use, if you do not know your kidney function — creatinine and eGFR, since kidney impairment is an absolute contraindication and is often silent. See Kidney Function Tests.
Before use, if you have any reason to suspect liver disease — liver enzymes. See Lab Tests.
During the episode — a urine dipstick and culture. This is the single most useful test, and not for the herb's sake: it confirms whether there is an infection at all and which antibiotic would work. A meaningful share of women with cystitis-like symptoms turn out not to have a bacterial infection, a point made in The diagnosis of urinary tract infection: a systematic review in Deutsches Ärzteblatt International (2010). See Urinalysis. PubMed search
Afterwards, if you developed any liver-type symptom — liver enzymes, and a clear account of everything you took.

Evidence Tiers at a Glance

Randomized clinical trial — negative. Uva ursi did not shorten symptoms of uncomplicated urinary infection versus placebo, which is the context for every risk on this page.
Randomized clinical trial — unfavourable. Replacing a single-dose antibiotic with uva ursi produced a higher symptom burden and more pyelonephritis.
Established toxicology. Hydroquinone is hepatotoxic at sufficient exposure and genotoxic in laboratory systems, with tumours in long-term rodent bioassays.
Formal risk assessment. Free hydroquinone delivered by standard bearberry preparations at recommended doses for short periods is small and within accepted margins — conditional on dose and duration.
Well-recognised, expected effect. Greenish-brown urine; nausea and gastric irritation from tannins.
Regulatory contraindication. Pregnancy, breastfeeding, children and adolescents, kidney disease; caution or avoidance in liver disease.
Pharmacological caution, not documented interaction. Nephrotoxic and hepatotoxic co-medication; alkalinising and acidifying agents; lithium; diuretics; iron.
Traditional use only. The alkaline-urine requirement; use for “gravel”; astringent soothing of the bladder.
Not supported. That short-course bearberry use causes cancer — no such evidence exists; that hydroquinone exposure can be dismissed at any duration — equally unsupported; that a cold preparation reduces hydroquinone exposure.

The Bottom Line

Uva ursi occupies an unusual and uncomfortable position. Its mechanism is genuinely interesting, its pharmacokinetics in humans are properly documented, and unlike most herbs it was actually put through a randomized placebo-controlled trial. The trial said no. And its proposed active moiety is a compound that regulators limit rather than encourage.

Put together:

No demonstrated benefit in the condition it is sold for.
A documented cost when it displaces treatment — more symptom-days and more kidney infections.
A hydroquinone ceiling that forbids the long or repeated use people most want.
A group of people for whom it is simply off-limits — pregnancy, breastfeeding, children, kidney disease, liver disease.
A red-flag list that matters far more than any of the above, because an escalating urinary infection is a real and reversible danger.

If someone still chooses to use it for a short course with none of the contraindications, the harm from one week at monograph doses appears to be small. But that is a very different sentence from “it works,” and this page is written so you can tell the two apart.

Key Research Papers

Cited as PubMed topic searches, with real titles, journals and years stated.

Risk assessment of free hydroquinone derived from Arctostaphylos uva-ursi folium herbal preparations. International Journal of Toxicology, 2013. The assessment underpinning short-course use. PubMed search
Hydroquinone: an evaluation of the human risks from its carcinogenic and mutagenic properties. Critical Reviews in Toxicology, 2007. The genotoxicity question examined directly. PubMed search
The toxicology of hydroquinone — relevance to occupational and environmental exposure. Critical Reviews in Toxicology, 1999. Liver and kidney toxicity background. PubMed search
Uva-ursi extract and ibuprofen as alternative treatments for uncomplicated urinary tract infection in women (ATAFUTI): a factorial randomized trial. Clinical Microbiology and Infection, 2019. The negative placebo-controlled trial. PubMed search
Herbal treatment with uva ursi extract versus fosfomycin in women with uncomplicated urinary tract infection in primary care: a randomized controlled trial. Clinical Microbiology and Infection, 2021. Higher symptom burden and more pyelonephritis in the herbal arm. PubMed search
Urinary excretion and metabolism of arbutin after oral administration of Arctostaphylos uvae ursi extract as film-coated tablets and aqueous solution in healthy humans. Journal of Clinical Pharmacology, 2002. Confirms systemic hydroquinone conjugate exposure. PubMed search
Urinary excretion of arbutin metabolites after oral administration of bearberry leaf extracts. Planta Medica, 2005. Independent pharmacokinetic confirmation. PubMed search
Bacterial deconjugation of arbutin by Escherichia coli. Phytomedicine, 2003. The local-activation hypothesis — and why the active moiety is hydroquinone. PubMed search
The diagnosis of urinary tract infection: a systematic review. Deutsches Ärzteblatt International, 2010. Why symptoms alone misclassify a meaningful share of episodes. PubMed search
Uncomplicated urinary tract infection. New England Journal of Medicine, 2012. Where “uncomplicated” stops applying — the clinical basis of the red-flag list. PubMed search
Botanical medicines for the urinary tract. World Journal of Urology, 2002. Review of urinary herbs and their cautions. PubMed search
Screening and treatment of urinary infection and asymptomatic bacteriuria in pregnancy — why pregnancy is the clearest case against self-treating. PubMed search
Regulatory restriction of hydroquinone in topical skin-lightening products — the same molecule limited by a different route. PubMed search

External Resources

European Medicines Agency — the bearberry-leaf monograph and assessment report behind the contraindications and duration limit.
US National Toxicology Program — toxicology and carcinogenesis evaluations of hydroquinone.
PubMed — index behind every citation above.
NCCIH — plain-language herb safety summaries.
NHS — when urinary symptoms need urgent assessment.
CDC — antibiotic use, resistance and urinary infection guidance.

Connections

Safety note. This page is general health education, not medical advice, and it cannot diagnose you. Uva ursi's active moiety is hydroquinone, which carries hepatotoxicity and genotoxicity concerns; use is limited to about one week at a time and a few short courses per year, and it must be avoided entirely in pregnancy, breastfeeding, childhood, and kidney or liver disease. Seek prompt medical care for fever, flank or back pain, nausea or vomiting, blood in the urine, urinary symptoms in pregnancy, in a man or in a child, for recurrent infection, or if you are not clearly improving within 48 hours — and urgent care if you feel very unwell, confused or breathless. Stop immediately and be assessed for yellowing of the skin or eyes, unusual fatigue, or reduced urine output. Always tell your doctor and pharmacist which herbal products you are taking.

Back to Table of Contents